About: British Maternal and Fetal Medicine Society, 25-26 April 2013, 16th Annual Conference, Convention Centre, Dublin, Ireland

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : British Maternal and Fetal Medicine Society, 25-26 April 2013, 16th Annual Conference, Convention Centre, Dublin, Ireland Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/bmj/periodical/fnn/2013/volume_98
Title	British Maternal and Fetal Medicine Society, 25-26 April 2013, 16th Annual Conference, Convention Centre, Dublin, Ireland
has manifestation of work	http://hub.abes.fr/bmj/periodical/fnn/2013/volume_98/issue_suppl1/m/web http://hub.abes.fr/bmj/periodical/fnn/2013/volume_98/issue_suppl1/m/print
Date Copyrighted	2013
Rights	© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
issue	Suppl 1
is Is Part Of of	PP.82 Does Use of Endo-Anal Ultrasound Effect the Management of Women Who Have Sustained a 3A Tear? PM.50 Maternity Services in the Irish Mass Media: An Analysis of Media Content from 2007-2012 PL.41 Specific MicroRNAs are Differentially Expressed in Labouring and Non-Labouring Human Myometrium at Term 3.1 Prediction of Fetal Compromise: The Use of Fetal Doppler Assessment in Normal Pregnancies Prior to Labour PF.07 Expression of 2, 3-Bisphosphoglycerate Mutase (BPGM) in Human Placenta PL.57 Audit of Midwives’ Knowledge of Neuraxial Analgesia in Labour PF.17 Fetal Biometry Revisited PP.73 Health Promotion of the Pregnant: Analysis of Some Intervening Variables PF.56 Cardiac Rhabdomyomas in Fetal Life and Beyond: A Single Centre 15-Year Experience PM.46 Reducing the Risk of Thrombosis and Embolism During the Puerperium: How Compliant Are Patients with Thromboprophylaxis Treatment? PM.09 The Effect of Glucocorticoids on Angiogenesis in the Human Placenta PL.39 Incidence and Risk Factors for Severe PPH: A Prospective South East Cohort Study (STOP) PL.56 The Construction of Computational Uterine Models from MRI Datasets of the Gravid Uterus and Post Partum Uterus PL.78 Maternal Request for a Caesarean Section in the Absence of Medical Indications PP.46 What Influences a Parent’s Decision-Making For Perinatal Autopsy? A Qualitative Investigation PL.14 Women’s Journeys through Birthplace Settings: Analysis of the Management and Experience of Escalation and Transfer During Labour and Birth 4.2 Variation in Beta Defensin 1 Genotype is Associated with Preterm Birth PF.54 Accuracy of Fetal Imaging For the Detection of Severe Abnormalities in Early Gestation PM.36 Resource Implications of Converting from a WHO/ADA Hybrid to IADPSG Criteria For Diagnosing GDM in a UK University Hospital PP.89 Preterm Pre-Labour Rupture of Membranes (PPROM) - When Clinicians Aspire to Find a Balance PL.10 Can the Institute for Healthcare Improvement “Model for Improvement” Reduce Obstetric Anal Sphincter Injuries (OASIS)? PL.80 Elective C-Sections: A Future Day Surgery Case? PP.57 Fetal Microchimerism Does Not Appear to Be Implicated in Epithelial Ovarian Cancer PP.68 ‘Take Care of the Pounds and the Pennies Will Take Care of Themselves’ - the Cost of Obesity in Obstetrics PP.86 Outcome of Pregnancies with Uterine Leiomyoma: A Population Based Retrospective Study PM.26 Quantification of Uterine Spiral Artery Transformation from 11 - 19 Weeks Gestation PL.29 Mobile Apps: The Future of Pregnancy Patient Information PL.68 When Should Twin Induction of Labour Start to Increase the Chances of Daytime Delivery? PL.100 Time to Discharge Following Uncomplicated Elective or Emergency Caesarean Section: is Patient Motivation the Major Determining Factor? PP.35 A Feasibility Study For a Randomised Controlled Trial of Management of Reduced Fetal Movements After 36 Weeks Gestation PP.36 The Impact of Unexplained Recurrent Miscarriage on Subsequent Pregnancy Outcomes PP.38 An Audit into the Outcomes of Pregnancy in Patients with Thrombophilia PP.42 Investigation of Neonatal Encephalopathy: The Lost Placental ‘Black Box’ PM.13 Offspring Birth Weight and Maternal Fasting Lipids in Women Screened For Gestational Diabetes Mellitus PP.67 Survey of Current Management of Reduced Fetal Movements in Scotland PM.43 Low Dose Aspirin in Pregnancy PL.33 Can We Improve Women’s Operative Vaginal Birth Experience? PF.09 Chromosomal Microarray (CMA) Use For the Prenatal Detection of Chromosome Anomalies: Model-Based Health Economic Evaluation PL.83 Trends in Caesarean Section in the East of Scotland PM.69 Haematinic Evaluation And Supplementation in a Normal Pregnancy PM.48 A Case of Haemoglobin Sun Prairie in Pregnancy 3.3 A Cluster Randomised Trial to Enhance Assessment and Repair of Birth Associated Perineal Trauma: The PEARLS Study PM.40 Lifestyle Intervention Reduces the Need For Insulin Therapy and Macromia in Gestational Diabetes Mellitus PP.03 Does the Apgar Score Matter? Investigating the Relationship Between a Low Score and Adverse Outcomes from Birth to Childhood PF.39 Clinical Relevance of Fetal Weight Estimation in Southwest Uganda PM.39 Postnatal Risk Assessment of Venous Thromboembolism (VTE) PF.36 Audit of Congenital Central Nervous System (CNS) Anomalies: Patterns of Referrals and Service Implications After the Introduction of First Trimester Screening and Second Trimester Anomaly Ultrasound in South East Scotland PL.77 Compliance in Obstetrics and Gynaecology Shifts Handover - Re-Audit PL.01 Molecular Markers of Early and Established Labour in Human Myometrium PL.23 Use of Quantitative Fetal Fibronectin May Improve Risk Assessment in Symptomatic Women at Risk of Preterm Birth PL.90 Documentation and Assessment of Continuous Intrapartum Electronic Fetal Heart Monitoring PP.58 Osteopathic Manipulative Treatment During Labour: An Exploratory Study PF.68 TORCH Screening, Where Are We Now? PM.75 Safety of Fondaparinux in Pregnancy- Experience of a North West Tertiary Referral Clinic PM.86 Melanoma in Pregnancy: A Case Report PM.90 Incidental Phaeochromocytoma in Pregnancy PL.30 Fathers’ Experiences of Pregnancy, Labour and Delivery PL.86 Audit of Placenta Accreta and its Antenatal Imaging PL.96 An Audit on Major Postpartum Haemorrhage at Queens Hospital, Romford PP.61 What is the Appropriate Management of a Pregnant Woman with Risk Factors For Gestational Diabetes (GDM) After an Incomplete OGTT Result? PL.16 Does the Use of Carbetocin Reduce Recovery Times at Caesarean Section? An Audit of Outcomes Following Routine Introduction of Carbetocin at Southmead Hospital PM.51 Challenges of Managing Pregnancy Complicated by Chronic Kidney Disease Stages 3-5: A Tertiary Centre’s Experience PF.38 Uptake of Free Fetal DNA For Aneuploidy Screening in Women of Advanced Maternal Age PP.07 Early Fetal Loss in Monochorionic and Dichorionic Twin Pregnancies: The Stork Multiple Pregnancy Cohort PP.41 Management of Obesity in Pregnancy in the West of Scotland PM.67 Bowel Perforation Following Severe Constipation in Pregnancy: A Case Report PM.35 Changing from 24-Hour Urinary Protein Collections to Protein-Creatinine Ratios: An Audit of One Hospital’s Experience of Trying to Reduce Admission Rates For Pre-Eclampsia PF.25 Relationship Between Maternal Antibody Level and Fetal Haemoglobin Concentration in Pregnancies Complicated by Rhesus-D Alloimmunization PM.12 The Management of Pregnant Women Attending Triage with Suspected Urinary Tract Infection (UTI) PM.59 Audit of the Management of Pregnant Women with Epilepsy (2011) PM.70 Comparative Study Between Gestational and Pregestational Diabetes in Relation to Glycemic Control as Regarding Fetal and Neonatal Outcome PM.78 Use of Intravenous Iron Sucrose Injections in the Treatment of Iron Deficiency Anaemia in Pregnancy PL.18 Validation of a Skill List of Non-Technical Skills for Obstetricians when Performing an Operative Vaginal Delivery PL.71 Pain in Labour: Comparative Study Between Women Unprepared and Prepared by the Psychoprophylactic Method PF.18 Umbilical Artery Dopplers in a Low Risk Population PP.65 Study of Factors Associated with Low Birth Weight PM.14 How Reassuring is a Normally Sited Placenta at the 18 - 20+6 Week Anomaly Scan at Excluding Placenta Praevia? PP.79 Characteristics and Outcomes of Teenage Mothers in Cambridge PL.17 Testing for Likelihood of Pre-Term Labour - a Descriptive Study of English Maternity Units 2011-2012 PL.27 Assessment of the Delivery of Cell Penetrating Peptides to Human Uteroplacental Cells PF.16 Maternal Plasma and Amniotic Fluid Cytokines in Monochorionic Twin Pregnancies Complicated by Twin-To-Twin Transfusion Syndrome PM.96 Early Onset Severe Pre-Eclampsia and HELLP Syndrome at 21 Weeks Gestation PF.32 Partial Urorectal Septum Malformation (pURSM) Sequence in England and Wales: Prevalence, Additional Anomalies, and Pregnancy Outcome PF.49 Term Admissions to the Neonatal Unit; Are They Avoidable? PP.74 Audit on the Management of Multiple Pregnancies and Review of Outcomes PM.62 Five Year Retrospective Review of Antenatal Lamivudine (LAM) to Reduce the Perinatal Transmission of Hepatitis B (HBV) PP.15 Mortality, Congenital Anomaly, & Maternal Risk Factors Across Ethnic Groups in Birmingham PF.77 Can Abnormal Maternal Serum Markers Analytes Be Used to Predict Obstetrical Outcomes? PF.43 Low Maternal Serum PAPP-A in the First Trimester and Pregnancy Outcome: An Experience Over 3 Years PF.37 Middle Cerebral Artery Dopplers in a Low-Risk Population PM.45 Increased NT - a Retrospective Audit from a University Hospital

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata